NEW YORK (TheStreet) -- CHANGE IN RATINGS
upgraded at Citi to Hold from Sell. Wafer starts still about to roll. Price target trimmed to $15 from $18.
upgraded at Goldman to Buy. Company should outperform in a slower growth environment.
upgraded at Goldman to Buy. Company will likely aggressively buy back its stock.
upgraded at Jefferies from Hold to Buy. $87 price target. Stock has pulled back since April and the purchasing environment in improving.
upgraded at Jefferies from Hold to Buy. $55 price target. Corporate travel activity has improved in the past few months.
Complete Production Services
( CPX) upgraded at Credit Suisse to Outperform from Neutral on increased earnings outlook, impressive margin growth. Price target jumped to $25 from $19.
TheStreet Research Center Professional Stock Reports and Ratings
Cognizant Technology Solutions
reinstated at BofA/Merrill with a Neutral rating and 458 price target. Growth potential not mispriced.
upgraded at Wells to Outperform. Estimates also boosted, as the company continues to grow in a slow environment.
estimates, target increased at Morgan Stanley. ETN estimates were raised through 2011. Company is seeing better demand across the board, outside of aerospace. Equal-weight rating and new $83 price target.
( HGSI) upgraded at Baird from Neutral to Outperform. $32 price target. Stock is down more than 20% this year, even though Benlysta will likely be approved by the FDA later this year.
rated new Perform at Oppenheimer. Valuation call, given weak natural gas prices.
downgraded at Goldman to Neutral. Estimates also cut, because of lower glass volume.
( PTV) downgraded at Goldman to Neutral. Valuation call.
downgraded at KBW to Market Perform. Management has limited visibility on future growth.
downgraded at Jefferies from Buy to Hold. $14 price target. License weakness could continue and the network management market is mature.
STOCK COMMENTS / EPS CHANGES
estimates upped at Morgan Stanley through 2011. Margins should continue to expand over the coming quarters. Overweight rating and $63 price target.
estimates lowered at Goldman through 2012, given the company's new guidance. Neutral rating and $63 price target.
estimates, target lowered at UBS. Shares of AMR now seen reaching $14. Estimates also cut, given the company's new guidance. Buy rating.
target upped at Goldman to $211. Industry has pricing power and should benefit from an aging car fleet. Neutral rating.
estimates, target boosted at Goldman. Shares of BIDU now seen reaching $90. Estimates also upped, given a higher customer count. Buy rating.
price target cut at Credit Suisse to $20 from $22. Large bookings miss in 1Q results. Maintain Neutral rating.
( CEPH) estimates, target raised at Goldman. Shares of CEPH now seen reaching $68. Estimates also increased, to match the company's new guidance. Neutral rating.
price target higher at BofA/Merrill. CF price target raised to $94 from $85. Expecting positive 2Q10 results. Maintain Buy rating.
estimates, target upped at UBS. Shares of CMA now seen reaching $28. Estimates also boosted, given the company's improved credit outlook. Sell rating.
price target higher at Citi. EMC price target raised by a dollar to $25. Selloff on modest 2010 beat represents buying opportunity. Maintain Buy rating.
estimates upped at Morgan Stanley through 2012. Company should have a positive launch for Sapien. Equal-weight rating.
price target boosted at Citi to $83 from $78. Another substantial beat and raise 2Q. Maintain Hold rating.
estimates, target raised at UBS. Shares of FFIV now seen reaching $83. Estimates also increased, as the company is posting solid growth and seeing record margins. Neutral rating.
estimates, target cut at Goldman. GHL estimates were reduced through 2012. Company is seeing lower advisory fees. Neutral rating and new $65 price target.
price target higher at BofA/Merrill. KO price target raised by a dollar to $63. 2Q volumes (+5%), margins (+210bps) better than forecasted. Maintain Buy rating.
estimates increased at UBS through 2012. Company continues to perform well, despite a murky macro outlook. Neutral rating and new $31 price target.
target, estimates boosted at Barclays. MAN price target raised by a dollar to $62. Robust 2Q performance and strong 3Q guidance. 2010 and 2011 EPS estimates lifted to $1.35 and $2.58, respectively. Maintain Overweight rating.
estimates increased at Goldman through 2012. Company is realizing better operating leverage. Neutral rating and $23 price target.
estimates boosted at BofA/Merrill. 2010, 2011, 2012 EPS estimates increased to $1.90, $2.03, $2.16, respectively. 2Q results showed tobacco momentum and execution. Maintain Buy and $24 price target.
estimates, target raised at Morgan Stanley. Shares of MO now seen reaching $22. Estimates also increased, given the better pricing and volume outlook. Equal-weight rating.
numbers changed at Barclays. MS 2010 EPS estimates raised to $2.97, 2011 cut to $3.15. MS benefitted from agency business model. Maintain $34 price target and Equal Weight rating.
estimates, target boosted at UBS. Shares of MTB now seen reaching $89. Estimates also upped, given the company's improved credit quality. Neutral rating.
target, estimates boosted at Credit Suisse. NFLX price target surged to $90 from $31 after 2Q10 revenue and EPS beat. 2010 and 2011 EPS estimates jumped to $2.82 and $3.69, respectively. Maintain Underperform rating.
estimates, target raised at Oppenheimer. Shares of NFLX now seen reaching $110. Estimates also increased, given increased streaming usage and international expansion. Underperform rating.
estimates, target raised at Goldman. Shares of QCOM now seen reaching $44. Estimates also increased, given continued smartphone growth. Buy rating.
estimates, target lowered at UBS. Shares of QCOM now seen reaching $45. Estimates also cut, given the company's lower margins. Buy rating.
estimates raised at Credit Suisse. QCOM 2010, 2011, 2012 EPS estimates increased to $2.33, $2.39, $2.50, respectively. Mixed 3Q results but CDMA/WCDMA market still seeing robust growth. Neutral rating and $40 price target.
target, estimates higher at BofA/Merrill. RHI price target lifted to $25 from $23 on strong 2Q10 results. 2010 and 2011 EPs estimates raised to 40 cents and 86 cents, respectively. Underperform rating.
estimates increased at Oppenheimer through 2011. Company has strong earnings momentum. Perform rating.
price target trimmed at Barclays to $26 from $28 on lower than expected 2011 estimates. 2010 and 2011 EPS estimate dropped to $1.23 and $1.40, respectively. Reiterate Equal Weight rating.
estimates, target upped at Goldman. TXT estimates were boosted through 2012. Company is seeing solid growth, outside of Cessna. Buy rating and new $25 price target.
estimates, target reduced at Morgan Stanley. Shares of USB now seen reaching $29. Estimates also cut, given higher legislative costs. Equal-weight rating.
numbers lowered at UBS. WDC estimates were cut through 2012. Company is seeing margin contraction, though further downside could be limited. Buy rating and new $34 price target.
2010 estimate raised at Barclays to $2.20 on strong 2Q10 performance. 2011 EPS estimate set at $3.00. Maintain Overweight rating and $36 price target.
estimates, target boosted at UBS. Shares of XLNX now seen reaching $35. Estimates also upped, given the company's secular growth trends. Buy rating.
TheStreet Research Center Professional Stock Reports and Ratings
This article was written by a staff member of TheStreet.